SC 13D

Company

ACRO BIOMEDICAL CO., LTD.

Filed

February 26, 2021

Accession Number

0001640334-21-000454

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →